MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Effects of Deep Brain Stimulation on Sleep Disturbances in Parkinson’s Disease: a 4-Year Follow-Up Study

    M. Tsalta-Mladenov, V. Dimitrova, M. Moynov, S. Andonova, Y. Enchev (Varna, Bulgaria)

    Objective: The aim of this study was to examine the effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on sleep disturbances (SD) in…
  • 2025 International Congress

    Non-Motor Symptom Comparisons by Race/Ethnicity in Thousands with PD Diagnosis

    G. Smith, R. Schneider, L. Stamm, P. Auinger, C. Venuto (Rochester, USA)

    Objective: To compare the incidence of non-motor symptoms (NMS) across racial and ethnic groups among individuals diagnosed with PD using the TriNetX platform, a global…
  • 2025 International Congress

    Determining the Influence of Cardiovascular Interventions and Factors on developing Parkinson’s Disease: Inferences from a Data-Driven Causal Forest Model

    V. Suresh, M. Hamed, D. Victor, M. Salgado (Lucknow, India)

    Objective: To investigate the directional influence between cardiovascular factors/interventions and Parkinson’s disease using causal inference based machine learning techniques. Background: Parkinson’s disease (PD) is a…
  • 2025 International Congress

    Autoimmune GFAP astrocytopathy as an Etiology of Opsoclonus-Myoclonus-Ataxia Syndrome

    T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)

    Objective: To report a case of opsoclonus-myoclonus-ataxia syndrome (OMAS) due to autoimmune GFAP astrocytopathy. Background: OMAS is associated with brainstem pathology. In adults, common causes…
  • 2025 International Congress

    Resolution Dependence of Machine Learning for Differential Diagnosis of Parkinsonian Eye Movements

    O. Bredemeyer, S. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To establish the extent to which high temporal resolution is required to differentiate between parkinsonian disease states from eye movements. Background: Previous studies have…
  • 2025 International Congress

    Multimodal and Agentic Simulated AI Patients for Bridging the gap in Parkinson Disease Education

    L. Okar, M. Fani (St. Louis, USA)

    Objective: To develop an AI training platform in PD counseling that utilizes real-time NLP processing, multimodal inputs/outputs, and adaptive reinforcement learning supported by immediate feedback…
  • 2025 International Congress

    Advancing Hypomimia Assessment in Parkinson’s Disease by Integrating a Continuous Monitoring Device into Clinical Practice

    A. Wiederhold, C. Gundler (Hamburg, Germany)

    Objective: We aim to establish a robust, continuous method for monitoring hypomimia in Parkinson’s disease (PD), bridging the gap between sporadic clinical evaluations and real-life…
  • 2025 International Congress

    Virtual Gait Lab: Assessment of Freezing of Gait in Parkinson’s Disease Using Virtual Reality

    K. Seo, M. Hara, S. Alaoui, S. Emoto, T. Ishii, K. Abe, G. Oyama, T. Yamamoto (Saitama, Japan)

    Objective: To develop and validate the effectiveness of a "Virtual Gait Lab" system using virtual reality (VR) technology for provoking and evaluating gait disturbances in…
  • 2025 International Congress

    Digital Measures for Clinical Trial Endpoints in Huntington’s Disease (MEND-HD): Study Design and Status Update

    J. Adams, J. Hausdorff, J. Mammen, P. Auinger, C. Dorney, S. Mahes, N. Shah, M. Tyo, M. Bjalme-Evans, L. Quinn (Rochester, USA)

    Objective: To evaluate and establish the analytical validation, reliability, and meaningfulness of digital measures of gait and chorea in early Huntington’s disease (HD). Background: HD…
  • 2025 International Congress

    Role of 7-Tesla MRI in assessing clinical symptoms in CSF1R-Related Disorders

    T. Chmiela, J. Dulski, A. Strongosky, E. Middlebrooks, Z. Wszolek (Katowice, Poland)

    Objective: To evaluate utility of 7-tesla magnetic resonance imaging (7T MRI) as a biomarker of CSR1R-Related Disorder (CSF1R-RD). Background: CSF1R-RD is a rapidly progressive neurodegenerative…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley